购物车
您的购物车当前为空
RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.

RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 41,650 | 10-14周 | |
| 50 mg | ¥ 54,200 | 10-14周 | |
| 100 mg | ¥ 69,800 | 10-14周 |
| 产品描述 | RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered. |
| 分子量 | 510.6 |
| 分子式 | C27H35FN6O3 |
| CAS No. | 2171388-28-4 |
| Smiles | O=C1C2(C=3C(N1C)=CC(=CC3F)N4C[C@@H](C)O[C@@H](C)C4)CCN(CC2)C=5NC6=C(C(=O)N5)CCCN6C |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多